NCT02366819 2026-03-30
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
University of Chicago
Phase 4 Suspended
Clinical Trials
10 trialsNCT05400122 2025-11-12
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
Case Comprehensive Cancer Center
Phase 1 Suspended
NCT05101616 2024-03-07
A Pilot Study of Neoadjuvant Chemotherapy With or Without Camrelizumab for Locally Advanced Gastric Cancer
Shanghai Minimally Invasive Surgery Center
Phase 1/2 Suspended
NCT05233007 2024-02-08
Upper GI Serial Tumour Biopsies
The Christie NHS Foundation Trust
Suspended
NCT01342653 2016-11-21
HIPEC
Hospital General Universitario Gregorio Marañon
Phase 2 Suspended
NCT01723306 2016-06-14
Phase II/Pilot Study of 2nd Generation Anti-CEA Designer T Cells in Adenocarcinomas
Roger Williams Medical Center
Phase 2 Suspended
NCT02686424 2016-02-23
ONCO-RD010CRT
Seoul National University Hospital
Suspended
NCT00209729 2010-05-26
Phase I/II Study of Oral S-1 Plus Docetaxel in Elderly Patients With Advanced Gastric Cancer.
Hokkaido Gastrointestinal Cancer Study Group
Phase 1/2 Suspended
NCT00568529 2010-05-26
Combination of Capecitabine and Oxaliplatin in Patients With Relapsed or Refractory Gastric Cancer
Fudan University
Phase 2 Suspended
NCT00209664 2006-02-02
Phase II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer
Hokkaido Gastrointestinal Cancer Study Group
Phase 2 Suspended